fda compound tirzepatide For Weight Loss & Metabolic Support | Rixa Health | Compound Tirzepatide | Tirzepatide Compound | Compound Tirzepatide For Weight Loss | Tirzepatide Compounded Medication FDA Allows Compounded Tirzepatide During

Monoamine Oxidase Inhibitors Monoamine oxidase inhibitors (MAOI) are usually used to treat depression

GLP-1 Peptide Medications GLP-1 peptides -- such as semaglutide and tirzepatide -- may be a more clinically validated option for patients whose primary goal is meaningful weight loss, and these are addressed in separate articles in this Peptide Series

A structured maintenance plan is recommended

The article lists fasting glucose, HbA1c, a lipid panel, and renal function as baseline labs before initiating semaglutide

The clinical protocol used in the SURMOUNT trials starts at 2.5 mg per week and increases in 2.5 mg increments, with 15 mg as the maximum weekly dose